• $273.0M
    Market Cap
  • -30.89%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
05/31/2026
05/31/2025
05/31/2024
05/31/2023
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
0
-100.00%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
53,000
0.00%
Gross Profit
0
N/A
0
N/A
0
-100.00%
213,000
0.00%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
-7.2M
+175.08%
-2.6M
-109.73%
Depreciation and Amortization Expense
17,000
-5.56%
18,000
-37.93%
29,000
-83.43%
175,000
-77.59%
Total Operating Expenses
38.6M
+499.29%
-9.7M
-153.50%
18.1M
-55.50%
40.6M
-72.14%
Operating Profit
-38.6M
-499.29%
9.7M
+153.50%
-18.1M
-55.50%
-40.6M
-72.09%
Interest Income
257,000
-54.51%
565,000
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
257,000
-54.51%
565,000
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-42.7M
-1,240.16%
3.7M
+107.51%
-49.8M
-37.56%
-79.8M
-62.14%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
0
-100.00%
407,000
N/A
N/A
N/A
N/A
N/A
Net Income
-42.7M
-1,240.16%
3.7M
+107.51%
-49.8M
-37.56%
-79.8M
-62.14%
Net Income from Continuing Operations Applicable to Common
-42.7M
-1,240.16%
3.7M
+107.51%
-49.8M
-37.56%
-79.8M
-62.14%
Basic EPS and Net Income
-0.03
N/A
0.00
+100.00%
-0.05
-50.00%
-0.10
-67.74%
Diluted EPS and Net Income
-0.03
N/A
0.00
+100.00%
-0.05
-50.00%
-0.10
-67.74%
Basic Weighted Average Shares
1.3B
+6.93%
1.2B
+24.37%
969.5M
+15.90%
836.5M
+23.58%
Diluted Weighted Average Shares
1.3B
+3.73%
1.2B
+28.20%
969.5M
+15.90%
836.5M
+23.58%
Balance Sheet
Cash and Cash Equivalents
11.9M
-0.43%
11.9M
+282.73%
3.1M
+22.39%
2.5M
-39.94%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
11.9M
-0.43%
11.9M
+282.73%
3.1M
+22.39%
2.5M
-39.94%
Total Current Assets
13.9M
-22.37%
17.9M
+65.31%
10.8M
+0.09%
10.8M
+2.76%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
95,000
-43.79%
169,000
-47.35%
321,000
-34.09%
487,000
+567.12%
Total Assets
14.0M
-22.57%
18.0M
+62.06%
11.1M
-1.38%
11.3M
-61.31%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
860,000
-96.84%
27.2M
-8.70%
29.8M
-13.44%
34.4M
-5.03%
Total Current Liabilities
53.7M
-23.81%
70.5M
-16.23%
84.2M
-29.73%
119.8M
-2.73%
Total Long-Term Debt
26.3M
+60.43%
16.4M
+2,199.44%
714,000
0.00%
714,000
-99.15%
Total Long-Term Liabilities
43.6M
0.00%
43.6M
0.00%
43.6M
+15,296.11%
283,000
-32.94%
Total Liabilities
123.7M
+8.42%
114.1M
-10.79%
127.9M
+5.88%
120.8M
-2.26%
Retained Earnings
-930.5M
+4.81%
-887.8M
-0.42%
-891.5M
+5.92%
-841.7M
+9.86%
Total Stockholders Equity
-109.7M
+14.24%
-96.0M
-17.74%
-116.8M
+6.63%
-109.5M
+16.00%
Total Shares Outstanding
1.4B
+9.95%
1.2B
+18.01%
1.1B
+15.23%
918.6M
+27.66%
Cash Flow
Cash from Operating Activities
-17.3M
+96.83%
-8.8M
-20.19%
-11.0M
-56.26%
-25.1M
-67.69%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
17.2M
+58.48%
10.9M
-7.61%
11.7M
-60.74%
29.9M
-37.67%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-266.70%
-1,139.14%
25.67%
+105.77%
-444.45%
+12.69%
-394.42%
+50.85%
Return on Equity
41.50%
+1,279.18%
-3.52%
-107.99%
44.06%
-43.73%
78.30%
-78.57%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
-100.00%
N/A
Current Ratio
0.26
+1.89%
0.25
+97.28%
0.13
+42.46%
0.09
+5.62%
Cash Ratio
0.22
+30.69%
0.17
+357.45%
0.04
+74.06%
0.02
-38.37%
Debt-to-Equity Ratio
-0.25
-45.42%
-0.45
+73.82%
-0.26
-18.55%
-0.32
-74.90%
Debt-to-Assets Ratio
1.95
-19.46%
2.42
-11.78%
2.74
-11.94%
3.11
-24.76%

Earnings & Revenue History

Debt-to-Assets

Cash Flow